ºÚÁÏÍø Comprehensive Sickle Cell Program
The Comprehensive Sickle Cell Program at the University of North Carolina – Chapel Hill is a program created to provide comprehensive care to patients with various sickle cell diseases. Sickle cell disease affects approximately 100,000 people in the United States and is most prevalent in African American and Latino populations. Our Sickle Cell Clinics are staffed by professionals with a commitment to providing the best possible care to patients with sickle cell disease. The adult and pediatric sickle cell staff provides services to more than 300 adults and 250 children annually at our clinics in Chapel Hill, Raleigh, Sanford, and Wilmington, NC. Additionally, our clinic sees patients with various thalassemia diseases.
Contact Us
For appointments, refills, or to talk to a provider call 984-974-2695 and select the appropriate option. This number is available nights and weekends as well for urgent patient questions or for providers from other hospitals.Ìý
For general inquiries please email: sicklecellprogram@med.unc.edu
For more information about our pediatric sickle cell program please click
Adult Clinics:Ìý
Chapel Hill Adult Sickle Cell Clinic (Primary Location):Ìý
ºÚÁÏÍø Outpatient Center at EastowneÌý
100 Eastowne Drive, 4th FloorÌý
Chapel Hill, NC 27514Ìý
Sanford Adult Sickle Cell Clinic:Ìý
ºÚÁÏÍø Specialty CareÌý
1301 Central DriveÌý
Sanford, NC 27330Ìý
Wilmington Adult Sickle Cell Clinic:Ìý
Novant Health Internal MedicineÌýÌý
1725 New Hanover Medical Park Dr.ÌýÌý
Wilmington, NC 28403Ìý
Apheresis
(For patients receiving red blood cell exchange):Ìý
984-974-1785Ìý
Meet the Team
Jane Little, MD, Director of Adult Sickle Cell Program- Attending
Patrick Ellsworth, MD, Attending
Sam Wilson, MD, Attending
, MD
Sherri Morris, AGNP, Nurse Practitioner
Tara Alin, ANP, Nurse Practitioner
Pharmacist
Bill Scheidler, MD, Psychiatrist (mental health)
Caitlan Meekins, Social Worker
Caroline Hale, LCSW, Psychotherapist & Program Coordinator (mental health)
Cheila Moore, Patient Navigator
David Wichlan, Research Coordinator